- $13.77m
- -$26.50m
- $43.95m
Brief: HOOKIPA Pharma Announces $21.25 Mln Equity Investment from Gilead Sciences
U.S. STOCKS ON THE MOVE-Zoom Video, HP Inc, Boeing
U.S. STOCKS ON THE MOVE-Kohl's, Bristol-Myers Squibb, 2Seventy Bio
U.S. STOCKS ON THE MOVE-MediciNova, PENN Entertainment, Medtronic
Hookipa rises as FDA clears marketing application for its HIV vaccine
Brief: Hookipa Pharma Reports Third Quarter 2023 Financial Results And Recent Business Highlights
Brief: HOOKIPA Pharma Q3 Net Income USD -19.066 Million
Brief: Hookipa Pharma Presents Additional Preliminary Phase 2 Data On HB-200
Brief: HOOKIPA Pharma Announces Publication Of Preclinical Data Of Hepatitis B Virus Therapeutic Vaccine Developed With Gilead Sciences
Hookipa Pharma Inc Reports Results For The Quarter Ended In June: Earnings Summary
Brief: HOOKIPA Pharma Q2 Net Income USD -18.016 Million
Hookipa Pharma Inc Expected To Post A Loss Of 21 Cents A Share: Earnings Preview
Brief: Hookipa Pharma Inc On August 3 Got Letter From Nasdaq That Co Is Not In Compliance With Nasdaq Listing Rule Of Minimum Bid Price Requirement
Brief: Hookipa Pharma Announces Pricing Of $50.0 Million Public Offering Of Common Stock And Non-Voting Convertible Preferred Stock
Brief: Hookipa Pharma Announces Positive Preliminary Phase 2 Data On HB-200 In Combination With Pembrolizumab In Patients With HPV16+ Head And Neck Cancers
Hookipa Pharma Inc Reports Results For The Quarter Ended In March: Earnings Summary
Brief: Hookipa Pharma Reports Q1 2023 Financial Results, Recent Business Highlights
Hookipa Pharma rises as partner Gilead begins hep B vaccine trial
Hookipa Pharma Inc Expected To Post A Loss Of 23 Cents A Share: Earnings Preview